News
-
-
PRESS RELEASE
Wellgistics Health Accelerates Digital Health Expansion of its Newly Announced RPM, RTM and CCM Pilot with Planned Acquisition of WellCare Today and its Proprietary Samsung Galaxy Watch Care Monitoring Program
Wellgistics Health, Inc. to acquire WellCare Today, integrating wearable tech for remote monitoring and creating clinical revenue opportunities for pharmacies and providers -
-
PRESS RELEASE
Wellgistics Health Announces Pilot MSO Collaboration with Kare PharmTech Targeting $14 Billion U.S. Market for CCM and RPM Services
Wellgistics Health, Inc. partners with Kare PharmTech and Kare Clinicals to pilot chronic care and remote patient monitoring services targeting U.S. RPM market growth -
-
PRESS RELEASE
Wellgistics Health and Kare PharmTech Execute Joint Venture Expanding Access to 200,000+ Patient Lives
Wellgistics Health, Inc. and Kare PharmTech's subsidiary join forces to enhance pharmaceutical access and fulfillment for 200,000+ patients. The joint venture combines technology and operations, aiming for streamlined patient access and improved efficiency -
-
PRESS RELEASE
Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Wellgistics Health, Inc. announces non-binding Letter of Intent to acquire Neuritek Therapeutics, a neuroscience-focused research organization, enhancing its healthcare platform -
-
PRESS RELEASE
Wellgistics Health Announces Launch of Diabetes Drug Brenzavvy(R) to Wellgistics Pharmacy Network
Wellgistics Health launches Brenzavvy to target the $16 billion SGLT-2 inhibitor market, focusing on patient education and reduced costs. Proprietary EinsteinRx AI platform supports broader market access and enhanced care experience for diabetics
